Cargando…

Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review

Antiangiogenic agents can induce a distinct MRI pattern in glioblastoma, characterized by a decrease in the contrast enhancement on T1‐weighted images and a simultaneous hyperintensity on T2‐weighted or fluid‐attenuated inversion recovery images.

Detalles Bibliográficos
Autores principales: Gatto, Lidia, Franceschi, Enrico, Tosoni, Alicia, Di Nunno, Vincenzo, Maggio, Ilaria, Tonon, Caterina, Lodi, Raffaele, Agati, Raffaele, Bartolini, Stefania, Brandes, Alba Ariela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380081/
https://www.ncbi.nlm.nih.gov/pubmed/34457284
http://dx.doi.org/10.1002/ccr3.4604
_version_ 1783741125063868416
author Gatto, Lidia
Franceschi, Enrico
Tosoni, Alicia
Di Nunno, Vincenzo
Maggio, Ilaria
Tonon, Caterina
Lodi, Raffaele
Agati, Raffaele
Bartolini, Stefania
Brandes, Alba Ariela
author_facet Gatto, Lidia
Franceschi, Enrico
Tosoni, Alicia
Di Nunno, Vincenzo
Maggio, Ilaria
Tonon, Caterina
Lodi, Raffaele
Agati, Raffaele
Bartolini, Stefania
Brandes, Alba Ariela
author_sort Gatto, Lidia
collection PubMed
description Antiangiogenic agents can induce a distinct MRI pattern in glioblastoma, characterized by a decrease in the contrast enhancement on T1‐weighted images and a simultaneous hyperintensity on T2‐weighted or fluid‐attenuated inversion recovery images.
format Online
Article
Text
id pubmed-8380081
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83800812021-08-27 Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review Gatto, Lidia Franceschi, Enrico Tosoni, Alicia Di Nunno, Vincenzo Maggio, Ilaria Tonon, Caterina Lodi, Raffaele Agati, Raffaele Bartolini, Stefania Brandes, Alba Ariela Clin Case Rep Case Reports Antiangiogenic agents can induce a distinct MRI pattern in glioblastoma, characterized by a decrease in the contrast enhancement on T1‐weighted images and a simultaneous hyperintensity on T2‐weighted or fluid‐attenuated inversion recovery images. John Wiley and Sons Inc. 2021-08-21 /pmc/articles/PMC8380081/ /pubmed/34457284 http://dx.doi.org/10.1002/ccr3.4604 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Gatto, Lidia
Franceschi, Enrico
Tosoni, Alicia
Di Nunno, Vincenzo
Maggio, Ilaria
Tonon, Caterina
Lodi, Raffaele
Agati, Raffaele
Bartolini, Stefania
Brandes, Alba Ariela
Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
title Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
title_full Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
title_fullStr Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
title_full_unstemmed Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
title_short Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
title_sort distinct mri pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: case report and literature review
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380081/
https://www.ncbi.nlm.nih.gov/pubmed/34457284
http://dx.doi.org/10.1002/ccr3.4604
work_keys_str_mv AT gattolidia distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview
AT franceschienrico distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview
AT tosonialicia distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview
AT dinunnovincenzo distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview
AT maggioilaria distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview
AT tononcaterina distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview
AT lodiraffaele distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview
AT agatiraffaele distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview
AT bartolinistefania distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview
AT brandesalbaariela distinctmripatternofpseudoresponseinrecurrentglioblastomamultiformetreatedwithregorafenibcasereportandliteraturereview